Child and Adolescent Clinical Psychopharmacology. Since that time, there have been enormous changes in the drug armamentarium and in the practice of child, adolescent, and adult psychopharmacology. Although advances in the field almost always occur in adult psychopharmacology first, the new drugs are being introduced into the practice of child and adolescent psychopharmacology more and more rapidly. By 1995, when the second edition of this book was published, the atypical neuroleptics and serotonin specific reuptake inhibitors (SSRIs) were being introduced into clinical practice with children and adolescents. Today they have replaced the standard neuroleptics and the tricyclic antidepressents as the first line drugs used by most child and adolescent psychopharmacologists to treat schizophrenia, major depressive disorder, and many other childhood disorders.